Latvia
· Delayed Price · Currency is EUR LJM1R Statistics
Total Valuation
AS Latvijas Juras medicinas centrs has a market cap or net worth of EUR 5.36 million. The enterprise value is 4.77 million.
| Market Cap | 5.36M |
| Enterprise Value | 4.77M |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 279,920 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 81.18.
| EV / Earnings | -10.54 |
| EV / Sales | 0.47 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 48.19 |
| EV / FCF | 81.18 |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | 0.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.08% and return on invested capital (ROIC) is 0.95%.
| Return on Equity (ROE) | -7.08% |
| Return on Assets (ROA) | 0.66% |
| Return on Capital (ROIC) | 0.95% |
| Revenue Per Employee | 27,950 |
| Profits Per Employee | -1,237 |
| Employee Count | 366 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 49.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.84% |
| 50-Day Moving Average | 7.06 |
| 200-Day Moving Average | 9.22 |
| Relative Strength Index (RSI) | 50.60 |
| Average Volume (20 Days) | 9 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AS Latvijas Juras medicinas centrs had revenue of EUR 10.23 million and -452,783 in losses. Loss per share was -0.57.
| Revenue | 10.23M |
| Gross Profit | 1.17M |
| Operating Income | 99,076 |
| Pretax Income | -451,894 |
| Net Income | -452,783 |
| EBITDA | 712,442 |
| EBIT | 99,076 |
| Loss Per Share | -0.57 |
Balance Sheet
| Cash & Cash Equivalents | 585,476 |
| Total Debt | n/a |
| Net Cash | 585,476 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.18M |
| Book Value Per Share | 7.72 |
| Working Capital | -571,174 |
Cash Flow
In the last 12 months, operating cash flow was 348,993 and capital expenditures -290,182, giving a free cash flow of 58,811.
| Operating Cash Flow | 348,993 |
| Capital Expenditures | -290,182 |
| Free Cash Flow | 58,811 |
| FCF Per Share | n/a |
Margins
Gross margin is 11.43%, with operating and profit margins of 0.97% and -4.43%.
| Gross Margin | 11.43% |
| Operating Margin | 0.97% |
| Pretax Margin | -4.42% |
| Profit Margin | -4.43% |
| EBITDA Margin | 6.96% |
| EBIT Margin | 0.97% |
| FCF Margin | 0.57% |
Dividends & Yields
AS Latvijas Juras medicinas centrs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.14% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AS Latvijas Juras medicinas centrs has an Altman Z-Score of 3.28.
| Altman Z-Score | 3.28 |
| Piotroski F-Score | n/a |